Elite Pharmaceuticals (ELTP) Interest Expenses (2010 - 2026)
Elite Pharmaceuticals' Interest Expenses was $73,103 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 54.0% from $158,926 a year earlier.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Interest Expenses (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Elite Pharmaceuticals' Interest Expenses was $503,342 through Jun 30, 2026, down 26.0% year-over-year; for FY2026 (ended Mar 31, 2026), it was $396,664, down 48.6% from FY2025.
- Interest Expenses shows a five-year compound annual growth rate of 8.8% (FY2021 to FY2026).
- In earlier fiscal years, Interest Expenses was $772,367 in FY2025 (+31.2%), $588,622 in FY2024 (-47.1%), $1.11 million in FY2023 (+480.1%) and $191,816 in FY2022 (-26.1%).
- The fiscal Q1 2027 figure marks the lowest quarterly Interest Expenses since fiscal Q4 2022.
- Compared with a year earlier, Interest Expenses was higher in 1 of the last six quarters, with an average decline of 18.7%.
- The best year-over-year quarter for Interest Expenses over five years was fiscal Q3 2023 (growth of 762.8%); the worst was fiscal Q2 2026 (a decline of 67.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | - |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 73,103.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73,103.00 |
| Sep 30, 2025 | 82,470.00 |
| Jun 30, 2025 | 158,926.00 |
| Mar 31, 2025 | 188,843.00 |
| Dec 31, 2024 | 77,607.00 |
| Sep 30, 2024 | 255,136.00 |
| Jun 30, 2024 | 250,781.00 |
| Mar 31, 2024 | 217,144.00 |
| Dec 31, 2023 | 121,628.00 |
| Sep 30, 2023 | 130,438.00 |
| Jun 30, 2023 | 119,412.00 |
| Mar 31, 2023 | 330,486.00 |
| Dec 31, 2022 | 322,681.00 |
| Sep 30, 2022 | 242,753.00 |
| Jun 30, 2022 | 216,787.00 |
| Mar 31, 2022 | 65,440.00 |
| Dec 31, 2021 | 37,400.00 |
| Sep 30, 2021 | 43,083.00 |
| Jun 30, 2021 | 45,893.00 |
| Mar 31, 2021 | 20,741.00 |
API Access
Elite Pharmaceuticals Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();